India FIPB Gives Penultimate Approval To Mylan $1.6 Billion Buy Of Agila
This article was originally published in PharmAsia News
Executive Summary
India's Foreign Investment Promotion Board has cleared Mylan's $1.6 billion acquisition of Agila Specialties, a specialist in generics injectables and a unit of Strides Arcolab.